These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25332207)

  • 41. G-protein receptor kinases 2, 5 and 6 redundantly modulate Smoothened-GATA transcriptional crosstalk in fetal mouse hearts.
    Franco A; Zhang L; Matkovich SJ; Kovacs A; Dorn GW
    J Mol Cell Cardiol; 2018 Aug; 121():60-68. PubMed ID: 29969579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.
    Bernt A; Rangrez AY; Eden M; Jungmann A; Katz S; Rohr C; Müller OJ; Katus HA; Sossalla ST; Williams T; Ritter O; Frank D; Frey N
    Sci Rep; 2016 Oct; 6():35758. PubMed ID: 27767176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
    Kuhn C; Frank D; Will R; Jaschinski C; Frauen R; Katus HA; Frey N
    J Biol Chem; 2009 Jun; 284(25):17320-17327. PubMed ID: 19372220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
    Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
    Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.
    Walther S; Awad S; Lonchyna VA; Blatter LA
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H856-66. PubMed ID: 24441548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
    Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
    Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Canonical and non-canonical actions of GRK5 in the heart".
    Traynham CJ; Hullmann J; Koch WJ
    J Mol Cell Cardiol; 2016 Mar; 92():196-202. PubMed ID: 26829117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoform- and tissue-specific regulation of the Ca(2+)-sensitive transcription factor NFAT in cardiac myocytes and heart failure.
    Rinne A; Kapur N; Molkentin JD; Pogwizd SM; Bers DM; Banach K; Blatter LA
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2001-9. PubMed ID: 20304816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.
    Duran J; Oyarce C; Pavez M; Valladares D; Basualto-Alarcon C; Lagos D; Barrientos G; Troncoso MF; Ibarra C; Estrada M
    PLoS One; 2016; 11(12):e0168255. PubMed ID: 27977752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.
    Mascareno E; Beckles D; Dhar-Mascareno M; Siddiqui MA
    Vascul Pharmacol; 2009; 51(2-3):198-204. PubMed ID: 19560554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents.
    Wu X; Chang B; Blair NS; Sargent M; York AJ; Robbins J; Shull GE; Molkentin JD
    J Clin Invest; 2009 Apr; 119(4):976-85. PubMed ID: 19287093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure.
    Remes A; Wagner AH; Schmiedel N; Heckmann M; Ruf T; Ding L; Jungmann A; Senger F; Katus HA; Ullrich ND; Frey N; Hecker M; Müller OJ
    Basic Res Cardiol; 2021 Jun; 116(1):38. PubMed ID: 34089101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
    Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
    J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct structural features of G protein-coupled receptor kinase 5 (GRK5) regulate its nuclear localization and DNA-binding ability.
    Johnson LR; Robinson JD; Lester KN; Pitcher JA
    PLoS One; 2013; 8(5):e62508. PubMed ID: 23658733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.